These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7812091)
21. A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%. Sihota R; Agarwal HC; Rajashekar YL Indian J Ophthalmol; 1996 Jun; 44(2):87-9. PubMed ID: 8916595 [TBL] [Abstract][Full Text] [Related]
22. Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients. Dietlein TS; Jordan JF; Lüke C; Schild A; Dinslage S; Krieglstein GK Acta Ophthalmol; 2008 Dec; 86(8):856-9. PubMed ID: 18494743 [TBL] [Abstract][Full Text] [Related]
23. An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension. Stewart WC; Leech J; Sharpe ED; Kulze J; Ellyn J; Day DG Am J Manag Care; 2002 Aug; 8(10 Suppl):S240-8. PubMed ID: 12188166 [TBL] [Abstract][Full Text] [Related]
24. The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy. Shin DH; McCracken MS; Bendel RE; Pearlman R; Juzych MS; Hughes BA; Schulz LL; Kim C; Baek NH Ophthalmology; 1999 Feb; 106(2):386-90. PubMed ID: 9951495 [TBL] [Abstract][Full Text] [Related]
25. Cost considerations of the new fixed combinations for glaucoma medical therapy. Ventura MP; Saheb NE; Solari HP; Saraiva VS; Vianna RN; Burnier MN J Clin Pharm Ther; 2005 Jun; 30(3):251-4. PubMed ID: 15896242 [TBL] [Abstract][Full Text] [Related]
26. [Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients]. Pisella PJ; Lala E; Parier V; Brignole F; Baudouin C J Fr Ophtalmol; 2003 Sep; 26(7):675-9. PubMed ID: 13130254 [TBL] [Abstract][Full Text] [Related]
27. [Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication]. Nenciu A; Stefan C; Ardelean C Oftalmologia; 2004; 48(1):35-42. PubMed ID: 15279417 [TBL] [Abstract][Full Text] [Related]
28. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension]. Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162 [TBL] [Abstract][Full Text] [Related]
30. [Effect of anti-glaucoma eyedrops on cell differentiation of the conjunctiva]. Steuhl KP; Knorr M; Frohn A; Thiel HJ Fortschr Ophthalmol; 1991; 88(6):865-9. PubMed ID: 1794823 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma. Gelatt KN; Larocca RD; Gelatt JK; Strubbe DT; MacKay EO Am J Vet Res; 1995 Oct; 56(10):1325-31. PubMed ID: 8928950 [TBL] [Abstract][Full Text] [Related]
32. Impact of administration angle on the cost of artificial tear solutions: does bottle positioning minimize wastage? Gaynes BI; Singa RM; Schaab G; Sorokin Y J Ocul Pharmacol Ther; 2007 Apr; 23(2):196-201. PubMed ID: 17444808 [TBL] [Abstract][Full Text] [Related]
33. Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs? Baudouin C Int J Clin Pharmacol Res; 1996; 16(1):29-41. PubMed ID: 9001927 [TBL] [Abstract][Full Text] [Related]
34. [The microbial count of insulin multiple-dose containers]. Thonke M; Hildebrandt R; Dressel H Pharmazie; 1990 Oct; 45(10):785-6. PubMed ID: 2089392 [TBL] [Abstract][Full Text] [Related]
35. How prostaglandins have changed the medical approach to glaucoma and its costs: an observational study of 2228 patients treated with glaucoma medications. De Natale R; Draghi E; Dorigo MT Acta Ophthalmol Scand; 2004 Aug; 82(4):393-6. PubMed ID: 15291930 [TBL] [Abstract][Full Text] [Related]
36. The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review. Yee RW Curr Opin Ophthalmol; 2007 Mar; 18(2):134-9. PubMed ID: 17301615 [TBL] [Abstract][Full Text] [Related]
37. [Flow cytometric analysis of HLA-DR, IL-6 and IL-8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments]. Bensoussan L; Blondin C; Baudouin C; Hamard P; Sabeh Afaki G; Creuzot-Garcher C; Warnet JM; Brignole-Baudouin F J Fr Ophtalmol; 2003 Oct; 26(8):782-9. PubMed ID: 14586218 [TBL] [Abstract][Full Text] [Related]
38. [A cost of illness study of diabetes mellitus]. von Ferber L; Köster I; Hauner H Gesundheitswesen; 1997 Jan; 59(1):17-22. PubMed ID: 9138642 [TBL] [Abstract][Full Text] [Related]
39. A Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in Italy. Christensen TL; Poulsen PB; Holmstrom S; Walt JG; Vetrugno M Curr Med Res Opin; 2005 Nov; 21(11):1837-44. PubMed ID: 16307705 [TBL] [Abstract][Full Text] [Related]
40. Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers. Kim MS; Choi CY; Kim JM; Chang HR; Woo HY Br J Ophthalmol; 2008 Nov; 92(11):1518-21. PubMed ID: 18782802 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]